EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Anticoagulation strategies in continuous renal replacement therapy

Matthieu Legrand iD, Ashita Tolwani

Seminars in Dialysis · 2021-11 · 34 (6) · 416-422

DOI: 10.1111/sdi.12959 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Dialysis, online erschienen am 08.03.2021. Verfasst von Matthieu Legrand und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, UCSF School of Medicine, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Acute Kidney Injury, Anticoagulants, Continuous Renal Replacement Therapy, Heparin. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common anticoagulant options for continuous renal replacement therapy (CRRT) include unfractionated heparin (UFH), regional citrate anticoagulation (RCA), and no anticoagulation. Less common anticoagulation options include UFH with protamine reversal, low‐molecular weight heparin (LMWH), thrombin antagonists, and platelet inhibiting agents. The choice of anticoagulant for CRRT should be determined by patient characteristics, local expertise, and ease of monitoring. The Kidney Disease Improving Global Outcomes (KDIGO) acute kidney injury guidelines recommend using RCA rather than UFH in patients who do not have contraindications to citrate and are with or without increased risk of bleeding. Monitoring should include evaluation of the anticoagulant effect, circuit life, filter efficacy, and complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryAnticoagulantsContinuous Renal Replacement TherapyHeparinRenal Replacement TherapyHeparin, Low-Molecular-WeightHumansRenal Dialysis

Stichwörter der Autor:innen

anticoagulationcitratecontinuous renal replacement therapy

Substanzen

AnticoagulantsHeparin, Low-Molecular-WeightHeparin

Autor:innen und Institutionen

  • Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, UCSF School of Medicine, San Francisco, CA, USA.
  • INI-CRCT Network, Nancy, France.
  • Department of Internal Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA.

ORCID-Profile: Matthieu Legrand

Zitieren

APA

Legrand, M., & Tolwani, A. (2021). Anticoagulation strategies in continuous renal replacement therapy. Seminars in Dialysis, 34(6), 416-422. https://doi.org/10.1111/sdi.12959

Vancouver

Legrand M, Tolwani A. Anticoagulation strategies in continuous renal replacement therapy. Seminars in Dialysis. 2021;34(6):416-422. doi:10.1111/sdi.12959

BibTeX
@article{Legrand2021,
  author = {Legrand, Matthieu and Tolwani, Ashita},
  title = {Anticoagulation strategies in continuous renal replacement therapy},
  journal = {Seminars in Dialysis},
  year = {2021},
  volume = {34},
  number = {6},
  pages = {416--422},
  doi = {10.1111/sdi.12959}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche